Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nocturnal free fatty acid rhythm and propranolol in obese and lean men
NL-OMON32829Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of propranolol in insulin resistance (IR) (2 cohorts), sponsored by Amsterdam University Medical Center. Primary endpoints: Change in nocturnal free fatty acid levels with or without beta-blockade and Difference in nocturnal free fatty acid levels between lean and obese subjects. Planned start Jan 2009; status: not yet recruiting.
02
Drugs
propranolol
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NL-OMON32829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32829.